The Enhancing Oncology Model allows pooling of groups of practices for quality measurement, which was not permitted under the OCM.
Moderator Stuart Staggs, MSIE, senior director, strategic programs, The US Oncology Network, and our panelists discuss a provision of the Enhancing Oncology Model (EOM) which would allow pooling of smaller practices into a larger group for quality measurement purposes. Not everyone thinks it's great idea. Panelists Stephen Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates and Community Oncology Alliance president, and Fred Divers, MD, chief medical officer, American Oncology Network and medical oncologist, Genesis Cancer and Blood Institute of Arkansas, discuss the concept.
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More